期刊文献+

蛋白质糖基化修饰:新一代肝病靶标的分子基础 被引量:1

Glycosylated modification of protein is the molecular basis of new targets in liver diseases
下载PDF
导出
摘要 肝病糖生物学研究是新一代肝病分子诊断标志物及肝癌治疗分子靶点研究的热点领域。不同肝病过程中伴随着复杂的蛋白质N-糖基化和O-糖基化修饰,这些糖基化修饰的变化导致了一些蛋白质翻译后修饰的改变,因而有可能成为未来新的肝病诊断标志物。这些修饰聚糖改变的基础在于肝细胞内部糖基转移酶和糖苷酶活性的变化,因而,对糖基转移酶和糖苷酶活性调控也有可能成为新一代抗癌药物研发的靶点。针对血清蛋白N-糖组分析也已经成为肝癌、肝硬化诊断的新方法。这些进展预示着肝病糖生物学研究将迎来一个新的时代。 The field of liver disease glycobiology is a new area of molecular target in liver disease.With the progression of disease,the glycosylation of protein results in complex modification of post-translation.The variations of glycan are consistent with activity of glycosyltransferase and glycolysase.Consequently,the glycosyltransferase and glycosylase related with liver disease may be a new treatment target of hepaticellular carcinma.The serum N-glycome analysis is a new method for diagnosing liver cirrhosis and hepaticellular carcinoma.These progressions suggest that a new era of liver glycobiology is coming.
出处 《胃肠病学和肝病学杂志》 CAS 2011年第4期302-305,共4页 Chinese Journal of Gastroenterology and Hepatology
基金 国家自然科学基金资助(No.30671875 No.30872243)
关键词 肝癌 糖基化 糖基转移酶 糖组 糖型 N-聚糖糖谱 Hepatocellular carcinoma Glycosylation Glycosyltransferase Glycome Glycoform N-glycan profile
  • 相关文献

参考文献29

  • 1Mondal G, Chatterjee U, Chawla YK, et al. Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients [J]. Glycoeonj J, 2011, 28(1): 1-9.
  • 2Zhang X, Teng Y, Fu Y, et al. Leetin-based biosensor stralegy for electrochemical assay of glycan expression on living cancer cells [ J ]. Anal Chem, 2010, 82(22) : 9455-9460.
  • 3Sarrats A, Saldova R, Pla E, et al. Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic panereatitis [ J ]. Proteomics Clin Appl, 2010, 4(4) : 432-448.
  • 4Klein A, Carre Y, Loavet A, et al. Immunoglobulins are the major glycoproleins involved in the modifications of total serum N-glycome in cirrhotic patients [J]. Proteomies Clin Appl, 2010, 4 (4) : 379-393.
  • 5Debruyne EN, Vanderschaeghe D, Van Vlierberghe H, et al. Diagnostic value of the hemopexin N-glyean profile in hepatoeellular carcinoma patients [J]. Clin Chem, 2010, 56(5) : 823-831.
  • 6Stewart SH, Comte-Waiters S, Bowen E, et al. Liver disease and HPLC quantification of disialotransferrin for heavy alcohol use: a case series [J]. Alcohol Clin Exp Res, 2010, 34(11): 1956-1960.
  • 7Chan CP, Mak TY, Chin KT, et al. N-linked glycosylation is required tbr optimal proteolytic activation of membrane-bound transcription faclor CREB-H [J]. J Cell Sci, 2010, 123(Pt9): 1438-1448.
  • 8West MB, Hanigan MH. γ-Glutamyl transpeptidase is a heavily N-gly-cosylated heterodimer in HepG2 cells [ J ]. Areh Bioehem Biophys 2010, 504(2): 177-181.
  • 9West MB, Segu ZM, Feasley CL, el al. Analysis of site-specifie glyeosylation of renal and hepatic Y-glutamyl transpeptidase fronl normal human tissue [J]. J Biol Chem, 2010, 285(38): 29511-29524.
  • 10Triantis V, Saeland E, Bijl N, et al. Glyeosylation of fibroblasl growth factor receptor 4 is a key regulator of fibroblasl growth factor 19-mediated down-regldation of eytochrome P450 7A1 [J]. Hepatology, 2010, 52(2) : 656-666.

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部